Meanwhile, the reduced level of β-catenin down-regulates the expression of TCF7L2, affecting the expression of the proglucagon gene in the ileum, thereby reducing the secretion of GLP-1, leading to T2D onset. The gene discussed is GCG; the disease is type 2 diabetes mellitus.